Loading resource…

Beaumont Hospital, Dublin, Ireland
Pulmonary involvement is common in patients with autoimmune and connective tissue diseases, often leading to significant morbidity and mortality. Interstitial lung disease is the most prevalent pulmonary manifestation associated with these conditions. The review highlights the need for screening and monitoring patients at risk for ILD, as well as the role of immunosuppressive therapies in managing these patients. It also discusses the complexities of treatment, including the challenges in distinguishing between treatment failures and complications.
No account needed